HuagongsheHuagongshe Chemistry Print Report · For research reference only
HCID 58063545, compound → HCID 58063612, compound
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | HCID 58063545 | HCID 58063545 | — |
| Reactant | HCID 58063577 | HCID 58063577 | — |
| Reactant | HCID 178418365 | HCID 178418365 | — |
| Product | HCID 58063612 | HCID 58063612 | — |
Reaction Steps
3-{4-[4-(2-Isopropylpyridin-4-yl)-3-methoxyphenyl]-1H-1,2,3-triazol-1-yl}-1-(2,2,2-trifluoroethyl)-1,3,4,5-tetrahydro-2H-1-benzazepin-2-one was prepared by using the same procedure described for 3-{4-[4-(2-ethylpyridin-4-yl)-3-methoxyphenyl]-1H-1,2,3-triazol-1-yl}-1-(2,2,2-trifluoroethyl)-1,3,4,5-tetrahydro-2H-1-benzazepin-2-one with isopropyl magnesium bromide (1M in THF, 189 μl, 0.189 mmol), and 3-{4-[4-(2-chloropyridin-4-yl)-3-methoxyphenyl]-1H-1,2,3-triazol-1-yl}-1-(2,2,2-trifluoroethyl)-1,3,4,5-tetrahydro-2H-1-benzazepin-2-one (50 mg, 0.095 mmol).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US08575150B2 |
| Source dataset | uspto-grants-2013_11 |
| ORD ID | ord-5595fe4ab2ca4bd1855058d499850440 |
| Source note | uspto-grants-2013_11 |